NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

Go back to NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

NRx Pharmaceuticals, Inc. (NRXP) Reports In-Line Q3 EPS

November 14, 2022 6:47 AM EST

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14).

For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.

... More